title: Murine macrophages kill the vegetative form of Bacillus anthracis.
abstract: Anti-protective antigen antibody was reported to enhance macrophage killing of ingested Bacillus anthracis spores, but it was unclear whether the antibody-mediated macrophage killing mechanism was directed against the spore itself or the vegetative form emerging from the ingested and germinating spore. To address this question, we compared the killing of germination-proficient (gp) and germination-deficient (DeltagerH) Sterne 34F2 strain spores by murine peritoneal macrophages. While macrophages similarly ingested both spores, only gp Sterne was killed at 5 h (0.37 log kill). Pretreatment of macrophages with gamma interferon (IFN-gamma) or opsonization with immunoglobulin G (IgG) isolated from a subject immunized with an anthrax vaccine enhanced the killing of Sterne to 0.49 and 0.73 log, respectively, but the combination of IFN-gamma and IgG was no better than either treatment alone. Under no condition was there killing of DeltagerH spores. To examine the ability of the exosporium to protect spores from macrophages, we compared the macrophage-mediated killing of nonsonicated (exosporium+) and sonicated (exosporium-) Sterne 34F2 spores. More sonicated spores than nonsonicated spores were killed at 5 h (0.98 versus 0.37 log kill, respectively). Pretreatment with IFN-gamma increased the sonicated spore killing to 1.39 log. However, the opsonization with IgG was no better than no treatment or pretreatment with IFN-gamma. We conclude that macrophages appear unable to kill the spore form of B. anthracis and that the exosporium may play a role in the protection of spores from macrophages.
authors.affiliation: Center for Vaccine Development, Department of Medicine, University of Maryland, 685 W. Baltimore Street, HSF I-480, Baltimore, MD 21201,USA.
authors.forename: Tae Jin
authors.initials: TJ
authors.lastname: Kang
authors.forename: Matthew J
authors.initials: MJ
authors.lastname: Fenton
authors.forename: Matthew A
authors.initials: MA
authors.lastname: Weiner
authors.forename: Stephen
authors.initials: S
authors.lastname: Hibbs
authors.forename: Subhendu
authors.initials: S
authors.lastname: Basu
authors.forename: Les
authors.initials: L
authors.lastname: Baillie
authors.forename: Alan S
authors.initials: AS
authors.lastname: Cross
mesh_terms: D000818:Animals; D022122:Anthrax Vaccines / Q000276:immunology; D000907:Antibodies, Bacterial / Q000276:immunology; D001408:Bacillus anthracis / Q000235:genetics / Q000254:growth & development* / Q000276:immunology* / Q000648:ultrastructure; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood / Q000276:immunology; D007371:Interferon-gamma / Q000276:immunology; D008264:Macrophages / Q000276:immunology*; D051379:Mice; D013171:Spores, Bacterial / Q000254:growth & development / Q000276:immunology; D013997:Time Factors
chemical_list: D022122:Anthrax Vaccines; D000907:Antibodies, Bacterial; D007074:Immunoglobulin G; D007371:Interferon-gamma